Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Pingyu Zhang, Xianbin Yang, Xiaoyan Ma, Davis R Ingram, Alexander J Lazar, Keila E Torres, Raphael E Pollock

ABSTRACT

BACKGROUND: Enhancer of zeste homolog 2 (EZH2) is a key epigenetic regulator in cancer cell survival, epithelial-mesenchymal transition, and tumorigenesis. Inhibition of EZH2 has become a promising therapeutic option for various human malignancies. Previously, we demonstrated that the EZH2/miR-30d/karyopherin (importin) beta 1 (KPNB1) signaling pathway is critical for malignant peripheral nerve sheath tumor (MPNST) cell survival in vitro and for tumorigenesis in vivo. Here, we sought to determine the antitumor effects of pharmacological inhibition of EZH2 on MPNST in vitro and in vivo. METHODS: We investigated the effects of an EZH2 inhibitor, 3-deazaneplanocin A (DZNep), on MPNST cell cycle, survival and apoptosis in vitro and on MPNST xenograft tumor growth in vivo. RESULTS: We found that DZNep treatment impaired MPNST cell viability and proliferation by inducing apoptosis and cell cycle arrest in vitro. Consistently, DZNep treatment also reduced EZH2 and KPNB1 protein levels and upregulated miR-30d expression in MPNST cells. Intraperitoneal administration of DZNep significantly suppressed MPNST tumor initiation and growth rates in a MPNST xenograft mouse model. Immunoblot and immunohistochemical analyses showed that DZNep downregulated EZH2/KPNB1 signaling in vivo, thereby inhibiting MPNST tumor cell proliferation, and induced cell death. We also found that EZH2 inhibited expression of another miR-30 family member, miR-30a, in MPNST cells. Similar to miR-30d, miR-30a inhibited KPNB1 by targeting the KPNB1 3' untranslated region in MPNST cells. Our data also showed that EZH2 suppressed miR-200b expression and induced epithelial-mesenchymal transition in MPNST cells. CONCLUSION: These findings demonstrated that DZNep, an inhibitor of S-adenosyl-methionine-dependent methyltransferase, suppressed EZH2/miR-30a,d/KPNB1 signaling and blocked MPNST tumor cell growth and survival in vitro and in vivo. More importantly, our study indicated that pharmacological interference of EZH2 is a potential therapeutic approach for MPNST. More... »

PAGES

55

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12943-015-0325-1

DOI

http://dx.doi.org/10.1186/s12943-015-0325-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1019356909

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25890085


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "3' Untranslated Regions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenosine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle Checkpoints", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enhancer of Zeste Homolog 2 Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epithelial-Mesenchymal Transition", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, SCID", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MicroRNAs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nerve Sheath Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polycomb Repressive Complex 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Up-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "beta Karyopherins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Pingyu", 
        "id": "sg:person.015570677357.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015570677357.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AM Biotechnologies (United States)", 
          "id": "https://www.grid.ac/institutes/grid.422386.9", 
          "name": [
            "AM Biotechnologies, 12521 Gulf Freeway, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Xianbin", 
        "id": "sg:person.01027064565.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027064565.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ma", 
        "givenName": "Xiaoyan", 
        "id": "sg:person.01371264125.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371264125.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ingram", 
        "givenName": "Davis R", 
        "id": "sg:person.0577544372.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577544372.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lazar", 
        "givenName": "Alexander J", 
        "id": "sg:person.010255222337.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010255222337.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Torres", 
        "givenName": "Keila E", 
        "id": "sg:person.01017635105.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017635105.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University", 
          "id": "https://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
            "Current address: Department of Surgical Oncology, Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pollock", 
        "givenName": "Raphael E", 
        "id": "sg:person.07756432137.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07756432137.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature11606", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000463489", 
          "https://doi.org/10.1038/nature11606"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-4598-10-40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000988131", 
          "https://doi.org/10.1186/1476-4598-10-40"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gad.1640608", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004123559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1210371110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006277788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1303800110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008002820"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10555-012-9387-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008427636", 
          "https://doi.org/10.1007/s10555-012-9387-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-1942", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012119188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gad.1524107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019255192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-07-294827", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019969469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-09-0013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020089960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/path.4294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023814700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0016282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024011852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.26264", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027650990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029188015", 
          "https://doi.org/10.1038/nrc1991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029188015", 
          "https://doi.org/10.1038/nrc1991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.2100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034851181", 
          "https://doi.org/10.1038/nm.2100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2011.551", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034969482", 
          "https://doi.org/10.1038/bjc.2011.551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2010.169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038480751", 
          "https://doi.org/10.1038/onc.2010.169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2010.169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038480751", 
          "https://doi.org/10.1038/onc.2010.169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-08-1008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039420703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.c800074200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041926183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-11-3027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043301400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2008.333", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046327348", 
          "https://doi.org/10.1038/onc.2008.333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s1462399409001227", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046667676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s1462399409001227", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046667676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-03-213496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049288500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-4598-9-265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051845270", 
          "https://doi.org/10.1186/1476-4598-9-265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2011-3068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064293283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/isl.1.3.9968", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072305044"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: Enhancer of zeste homolog 2 (EZH2) is a key epigenetic regulator in cancer cell survival, epithelial-mesenchymal transition, and tumorigenesis. Inhibition of EZH2 has become a promising therapeutic option for various human malignancies. Previously, we demonstrated that the EZH2/miR-30d/karyopherin (importin) beta 1 (KPNB1) signaling pathway is critical for malignant peripheral nerve sheath tumor (MPNST) cell survival in vitro and for tumorigenesis in vivo. Here, we sought to determine the antitumor effects of pharmacological inhibition of EZH2 on MPNST in vitro and in vivo.\nMETHODS: We investigated the effects of an EZH2 inhibitor, 3-deazaneplanocin A (DZNep), on MPNST cell cycle, survival and apoptosis in vitro and on MPNST xenograft tumor growth in vivo.\nRESULTS: We found that DZNep treatment impaired MPNST cell viability and proliferation by inducing apoptosis and cell cycle arrest in vitro. Consistently, DZNep treatment also reduced EZH2 and KPNB1 protein levels and upregulated miR-30d expression in MPNST cells. Intraperitoneal administration of DZNep significantly suppressed MPNST tumor initiation and growth rates in a MPNST xenograft mouse model. Immunoblot and immunohistochemical analyses showed that DZNep downregulated EZH2/KPNB1 signaling in vivo, thereby inhibiting MPNST tumor cell proliferation, and induced cell death. We also found that EZH2 inhibited expression of another miR-30 family member, miR-30a, in MPNST cells. Similar to miR-30d, miR-30a inhibited KPNB1 by targeting the KPNB1 3' untranslated region in MPNST cells. Our data also showed that EZH2 suppressed miR-200b expression and induced epithelial-mesenchymal transition in MPNST cells.\nCONCLUSION: These findings demonstrated that DZNep, an inhibitor of S-adenosyl-methionine-dependent methyltransferase, suppressed EZH2/miR-30a,d/KPNB1 signaling and blocked MPNST tumor cell growth and survival in vitro and in vivo. More importantly, our study indicated that pharmacological interference of EZH2 is a potential therapeutic approach for MPNST.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12943-015-0325-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2411261", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2699159", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1031030", 
        "issn": [
          "1476-4598"
        ], 
        "name": "Molecular Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway", 
    "pagination": "55", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5c3a7cd933cacbffa677ea5b01c819cb69bdb244d47b705d388342f2bd10aa74"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25890085"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101147698"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12943-015-0325-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1019356909"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12943-015-0325-1", 
      "https://app.dimensions.ai/details/publication/pub.1019356909"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88230_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12943-015-0325-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12943-015-0325-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12943-015-0325-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12943-015-0325-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12943-015-0325-1'


 

This table displays all metadata directly associated to this object as RDF triples.

299 TRIPLES      21 PREDICATES      77 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12943-015-0325-1 schema:about N04172189e72e42a5bd6adb8d22288c80
2 N0f251dedef434f6ba56a47ba2021bd5f
3 N1249da5b4e874a8b802beffa6ef390c8
4 N12d9172036c84456a96440d68eb96914
5 N2ae4cf290a3c4fa59026ea1f7ce5c667
6 N375c8a301dac486f9d87b1f6d0141920
7 N6811b99fcc3045e89017ad58266bfb0b
8 N774df1aa5a594f9f9292c5967aa84bb7
9 N89d7f9d7f6d1403bb758cd5b0a63f464
10 N8f34a70d324e449db20b596adf2a9e8f
11 N8f82c3de93a441178dba5bf1c4dd7245
12 N940c564ada7f4b75822c0a86f99ed5ef
13 Na72bc5fdd83c4584a14b102b5a5b021f
14 Nab218e7126594346a43207a10fbc02c3
15 Nc56e91a3e5ee492cb98c73b89617170f
16 Nc9c08e584657445aba38deed2f75e72c
17 Ncf2a1d2cd17c4d7ba5c8bc00e0fae322
18 Ne0e51f2821ee4a699bf60a11c0abd8da
19 Ne44b2102bfa6469c9046d2f18fd76c1e
20 Ne969fd9a867c469bb356cf8a8978d2c6
21 Nefec76259f5c46479cc2dcad36df0091
22 Nf42049d818444c1d83f0cd974fad2709
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author N68e51aa8cc3b4e75b5a3d6cdc390e64c
26 schema:citation sg:pub.10.1007/s10555-012-9387-3
27 sg:pub.10.1038/bjc.2011.551
28 sg:pub.10.1038/nature11606
29 sg:pub.10.1038/nm.2100
30 sg:pub.10.1038/nrc1991
31 sg:pub.10.1038/onc.2008.333
32 sg:pub.10.1038/onc.2010.169
33 sg:pub.10.1186/1476-4598-10-40
34 sg:pub.10.1186/1476-4598-9-265
35 https://doi.org/10.1002/ijc.26264
36 https://doi.org/10.1002/path.4294
37 https://doi.org/10.1017/s1462399409001227
38 https://doi.org/10.1073/pnas.1210371110
39 https://doi.org/10.1073/pnas.1303800110
40 https://doi.org/10.1074/jbc.c800074200
41 https://doi.org/10.1101/gad.1524107
42 https://doi.org/10.1101/gad.1640608
43 https://doi.org/10.1158/0008-5472.can-08-1942
44 https://doi.org/10.1158/0008-5472.can-11-3027
45 https://doi.org/10.1158/1535-7163.mct-08-1008
46 https://doi.org/10.1158/1535-7163.mct-09-0013
47 https://doi.org/10.1182/blood-2009-03-213496
48 https://doi.org/10.1182/blood-2010-07-294827
49 https://doi.org/10.1210/jc.2011-3068
50 https://doi.org/10.1371/journal.pone.0016282
51 https://doi.org/10.4161/isl.1.3.9968
52 schema:datePublished 2015-12
53 schema:datePublishedReg 2015-12-01
54 schema:description BACKGROUND: Enhancer of zeste homolog 2 (EZH2) is a key epigenetic regulator in cancer cell survival, epithelial-mesenchymal transition, and tumorigenesis. Inhibition of EZH2 has become a promising therapeutic option for various human malignancies. Previously, we demonstrated that the EZH2/miR-30d/karyopherin (importin) beta 1 (KPNB1) signaling pathway is critical for malignant peripheral nerve sheath tumor (MPNST) cell survival in vitro and for tumorigenesis in vivo. Here, we sought to determine the antitumor effects of pharmacological inhibition of EZH2 on MPNST in vitro and in vivo. METHODS: We investigated the effects of an EZH2 inhibitor, 3-deazaneplanocin A (DZNep), on MPNST cell cycle, survival and apoptosis in vitro and on MPNST xenograft tumor growth in vivo. RESULTS: We found that DZNep treatment impaired MPNST cell viability and proliferation by inducing apoptosis and cell cycle arrest in vitro. Consistently, DZNep treatment also reduced EZH2 and KPNB1 protein levels and upregulated miR-30d expression in MPNST cells. Intraperitoneal administration of DZNep significantly suppressed MPNST tumor initiation and growth rates in a MPNST xenograft mouse model. Immunoblot and immunohistochemical analyses showed that DZNep downregulated EZH2/KPNB1 signaling in vivo, thereby inhibiting MPNST tumor cell proliferation, and induced cell death. We also found that EZH2 inhibited expression of another miR-30 family member, miR-30a, in MPNST cells. Similar to miR-30d, miR-30a inhibited KPNB1 by targeting the KPNB1 3' untranslated region in MPNST cells. Our data also showed that EZH2 suppressed miR-200b expression and induced epithelial-mesenchymal transition in MPNST cells. CONCLUSION: These findings demonstrated that DZNep, an inhibitor of S-adenosyl-methionine-dependent methyltransferase, suppressed EZH2/miR-30a,d/KPNB1 signaling and blocked MPNST tumor cell growth and survival in vitro and in vivo. More importantly, our study indicated that pharmacological interference of EZH2 is a potential therapeutic approach for MPNST.
55 schema:genre research_article
56 schema:inLanguage en
57 schema:isAccessibleForFree true
58 schema:isPartOf N260260b2ffc0467692a5ccbcbd03777b
59 N686bf2deee504c10ab34fdc1546c6aeb
60 sg:journal.1031030
61 schema:name Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway
62 schema:pagination 55
63 schema:productId N868364d435be401e9d0645866d89d555
64 Ncedb6688513a445b83f056a95fa422c4
65 Ncf67800821074ba1a1c11de046e2a295
66 Ndf9ad506739847968183e12dca8ee80b
67 Ne95187370e8740bfb5f8e55c6fa5e0e9
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019356909
69 https://doi.org/10.1186/s12943-015-0325-1
70 schema:sdDatePublished 2019-04-11T13:08
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N56e5a56dccf3424ca06c0ea3b0bd1815
73 schema:url http://link.springer.com/10.1186%2Fs12943-015-0325-1
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N04172189e72e42a5bd6adb8d22288c80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Cell Survival
79 rdf:type schema:DefinedTerm
80 N0f251dedef434f6ba56a47ba2021bd5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Epithelial-Mesenchymal Transition
82 rdf:type schema:DefinedTerm
83 N1249da5b4e874a8b802beffa6ef390c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Cell Cycle Checkpoints
85 rdf:type schema:DefinedTerm
86 N12d9172036c84456a96440d68eb96914 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Up-Regulation
88 rdf:type schema:DefinedTerm
89 N260260b2ffc0467692a5ccbcbd03777b schema:issueNumber 1
90 rdf:type schema:PublicationIssue
91 N2ae4cf290a3c4fa59026ea1f7ce5c667 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Female
93 rdf:type schema:DefinedTerm
94 N353408f0b64d47e78408bf3237a17837 rdf:first sg:person.0577544372.22
95 rdf:rest Nabf3bcf598b04d669bdff56255c7ae80
96 N375c8a301dac486f9d87b1f6d0141920 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Cell Cycle
98 rdf:type schema:DefinedTerm
99 N56e5a56dccf3424ca06c0ea3b0bd1815 schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 N6811b99fcc3045e89017ad58266bfb0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Apoptosis
103 rdf:type schema:DefinedTerm
104 N686bf2deee504c10ab34fdc1546c6aeb schema:volumeNumber 14
105 rdf:type schema:PublicationVolume
106 N68e51aa8cc3b4e75b5a3d6cdc390e64c rdf:first sg:person.015570677357.00
107 rdf:rest Ne18638bf2ace4360aecf7b60ecdcbbb2
108 N774df1aa5a594f9f9292c5967aa84bb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name beta Karyopherins
110 rdf:type schema:DefinedTerm
111 N868364d435be401e9d0645866d89d555 schema:name readcube_id
112 schema:value 5c3a7cd933cacbffa677ea5b01c819cb69bdb244d47b705d388342f2bd10aa74
113 rdf:type schema:PropertyValue
114 N89d7f9d7f6d1403bb758cd5b0a63f464 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Mice
116 rdf:type schema:DefinedTerm
117 N8f34a70d324e449db20b596adf2a9e8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Cell Line, Tumor
119 rdf:type schema:DefinedTerm
120 N8f82c3de93a441178dba5bf1c4dd7245 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Down-Regulation
122 rdf:type schema:DefinedTerm
123 N940c564ada7f4b75822c0a86f99ed5ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Animals
125 rdf:type schema:DefinedTerm
126 N9afc14d62c344ea1aadfc88f8c8b99aa rdf:first sg:person.07756432137.83
127 rdf:rest rdf:nil
128 Na72bc5fdd83c4584a14b102b5a5b021f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Humans
130 rdf:type schema:DefinedTerm
131 Na8dbaf73a56b448baba022bb936a83b4 rdf:first sg:person.01017635105.71
132 rdf:rest N9afc14d62c344ea1aadfc88f8c8b99aa
133 Nab218e7126594346a43207a10fbc02c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Nerve Sheath Neoplasms
135 rdf:type schema:DefinedTerm
136 Nabf3bcf598b04d669bdff56255c7ae80 rdf:first sg:person.010255222337.53
137 rdf:rest Na8dbaf73a56b448baba022bb936a83b4
138 Nc56e91a3e5ee492cb98c73b89617170f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Enhancer of Zeste Homolog 2 Protein
140 rdf:type schema:DefinedTerm
141 Nc9c08e584657445aba38deed2f75e72c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Antineoplastic Agents
143 rdf:type schema:DefinedTerm
144 Ncedb6688513a445b83f056a95fa422c4 schema:name nlm_unique_id
145 schema:value 101147698
146 rdf:type schema:PropertyValue
147 Ncf2a1d2cd17c4d7ba5c8bc00e0fae322 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Polycomb Repressive Complex 2
149 rdf:type schema:DefinedTerm
150 Ncf67800821074ba1a1c11de046e2a295 schema:name doi
151 schema:value 10.1186/s12943-015-0325-1
152 rdf:type schema:PropertyValue
153 Ndf9ad506739847968183e12dca8ee80b schema:name dimensions_id
154 schema:value pub.1019356909
155 rdf:type schema:PropertyValue
156 Ne0e51f2821ee4a699bf60a11c0abd8da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Adenosine
158 rdf:type schema:DefinedTerm
159 Ne18638bf2ace4360aecf7b60ecdcbbb2 rdf:first sg:person.01027064565.53
160 rdf:rest Ne7665ec5c4904eaa9d54c840576def4e
161 Ne44b2102bfa6469c9046d2f18fd76c1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Signal Transduction
163 rdf:type schema:DefinedTerm
164 Ne7665ec5c4904eaa9d54c840576def4e rdf:first sg:person.01371264125.47
165 rdf:rest N353408f0b64d47e78408bf3237a17837
166 Ne95187370e8740bfb5f8e55c6fa5e0e9 schema:name pubmed_id
167 schema:value 25890085
168 rdf:type schema:PropertyValue
169 Ne969fd9a867c469bb356cf8a8978d2c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name MicroRNAs
171 rdf:type schema:DefinedTerm
172 Nefec76259f5c46479cc2dcad36df0091 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name 3' Untranslated Regions
174 rdf:type schema:DefinedTerm
175 Nf42049d818444c1d83f0cd974fad2709 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Mice, SCID
177 rdf:type schema:DefinedTerm
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
182 schema:name Oncology and Carcinogenesis
183 rdf:type schema:DefinedTerm
184 sg:grant.2411261 http://pending.schema.org/fundedItem sg:pub.10.1186/s12943-015-0325-1
185 rdf:type schema:MonetaryGrant
186 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1186/s12943-015-0325-1
187 rdf:type schema:MonetaryGrant
188 sg:grant.2699159 http://pending.schema.org/fundedItem sg:pub.10.1186/s12943-015-0325-1
189 rdf:type schema:MonetaryGrant
190 sg:journal.1031030 schema:issn 1476-4598
191 schema:name Molecular Cancer
192 rdf:type schema:Periodical
193 sg:person.01017635105.71 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
194 schema:familyName Torres
195 schema:givenName Keila E
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017635105.71
197 rdf:type schema:Person
198 sg:person.010255222337.53 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
199 schema:familyName Lazar
200 schema:givenName Alexander J
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010255222337.53
202 rdf:type schema:Person
203 sg:person.01027064565.53 schema:affiliation https://www.grid.ac/institutes/grid.422386.9
204 schema:familyName Yang
205 schema:givenName Xianbin
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027064565.53
207 rdf:type schema:Person
208 sg:person.01371264125.47 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
209 schema:familyName Ma
210 schema:givenName Xiaoyan
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371264125.47
212 rdf:type schema:Person
213 sg:person.015570677357.00 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
214 schema:familyName Zhang
215 schema:givenName Pingyu
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015570677357.00
217 rdf:type schema:Person
218 sg:person.0577544372.22 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
219 schema:familyName Ingram
220 schema:givenName Davis R
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577544372.22
222 rdf:type schema:Person
223 sg:person.07756432137.83 schema:affiliation https://www.grid.ac/institutes/grid.261331.4
224 schema:familyName Pollock
225 schema:givenName Raphael E
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07756432137.83
227 rdf:type schema:Person
228 sg:pub.10.1007/s10555-012-9387-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008427636
229 https://doi.org/10.1007/s10555-012-9387-3
230 rdf:type schema:CreativeWork
231 sg:pub.10.1038/bjc.2011.551 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034969482
232 https://doi.org/10.1038/bjc.2011.551
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/nature11606 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000463489
235 https://doi.org/10.1038/nature11606
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/nm.2100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034851181
238 https://doi.org/10.1038/nm.2100
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/nrc1991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029188015
241 https://doi.org/10.1038/nrc1991
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/onc.2008.333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046327348
244 https://doi.org/10.1038/onc.2008.333
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/onc.2010.169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038480751
247 https://doi.org/10.1038/onc.2010.169
248 rdf:type schema:CreativeWork
249 sg:pub.10.1186/1476-4598-10-40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000988131
250 https://doi.org/10.1186/1476-4598-10-40
251 rdf:type schema:CreativeWork
252 sg:pub.10.1186/1476-4598-9-265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051845270
253 https://doi.org/10.1186/1476-4598-9-265
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1002/ijc.26264 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027650990
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1002/path.4294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023814700
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1017/s1462399409001227 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046667676
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1073/pnas.1210371110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006277788
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1073/pnas.1303800110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008002820
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1074/jbc.c800074200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041926183
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1101/gad.1524107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019255192
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1101/gad.1640608 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004123559
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1158/0008-5472.can-08-1942 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012119188
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1158/0008-5472.can-11-3027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043301400
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1158/1535-7163.mct-08-1008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039420703
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1158/1535-7163.mct-09-0013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020089960
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1182/blood-2009-03-213496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049288500
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1182/blood-2010-07-294827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019969469
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1210/jc.2011-3068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064293283
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1371/journal.pone.0016282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024011852
286 rdf:type schema:CreativeWork
287 https://doi.org/10.4161/isl.1.3.9968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072305044
288 rdf:type schema:CreativeWork
289 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
290 schema:name Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
291 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
292 rdf:type schema:Organization
293 https://www.grid.ac/institutes/grid.261331.4 schema:alternateName The Ohio State University
294 schema:name Current address: Department of Surgical Oncology, Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA
295 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
296 rdf:type schema:Organization
297 https://www.grid.ac/institutes/grid.422386.9 schema:alternateName AM Biotechnologies (United States)
298 schema:name AM Biotechnologies, 12521 Gulf Freeway, Houston, TX, USA
299 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...